Evaluation of alternative calculation methods for determining low-density lipoprotein cholesterol in hemodialysis patients

被引:8
作者
Bairaktari, ET [1 ]
Tzallas, C
Kalientzidou, M
Tselepis, AD
Siamopoulos, KC
Seferiadis, KI
Elisaf, MS
机构
[1] Univ Ioannina, Univ Hosp, Sch Med, Biochem Lab, GR-45110 Ioannina, Greece
[2] Univ Ioannina, Univ Hosp, Sch Med, Dept Nephrol, GR-45110 Ioannina, Greece
[3] Univ Ioannina, Dept Chem, GR-45110 Ioannina, Greece
[4] Univ Ioannina, Univ Hosp, Sch Med, Dept Internal Med, GR-45110 Ioannina, Greece
关键词
LDL-cholesterol calculation; Friedewald equation; apolipoprotein B method comparison; hemodialysis patients; small dense LDL;
D O I
10.1016/j.clinbiochem.2003.10.018
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
objectives: To evaluate alternative equations for the estimation of low-density lipoprotein cholesterol (LDL-C) than the Friedewald equation in hemodialysis patients. Design and methods: The equations LDL-C = 0.41TC - 0.14TG + 0.66ApoB - 10.43 and LDL-C = 0.94TC - 0.94HDL-C - 0.19TG were evaluated in 86 patients and compared with the Friedewald equation and the ultracentrifugation procedure. Results: The alternative equations yield significantly lower bias than the Friedewald equation and are less affected by increased triglycerides (TG) levels. Conclusion: The alternative equations for LDL-C yield slightly better results than the Friedewald equation especially in hypertriglyceridemia. (C) 2004 The Canadian Society of Clinical Chemists. All rights reserved.
引用
收藏
页码:937 / 940
页数:4
相关论文
共 10 条
[1]   Premature cardiovascular disease in chronic renal failure [J].
Baigent, C ;
Burbury, K ;
Wheeler, D .
LANCET, 2000, 356 (9224) :147-152
[2]   Evaluation of five methods for determining low-density lipoprotein cholesterol (LDL-C) in hemodialysis patients [J].
Bairaktari, E ;
Elisaf, M ;
Tzallas, C ;
Karabina, SA ;
Tselepis, AD ;
Siamopoulos, KC ;
Tsolas, O .
CLINICAL BIOCHEMISTRY, 2001, 34 (08) :593-602
[3]   Estimation of LDL cholesterol based on the Friedewald formula and on apo B levels [J].
Bairaktari, E ;
Hatzidimou, K ;
Tzallas, C ;
Vini, M ;
Katsaraki, A ;
Tselepis, A ;
Elisaf, M ;
Tsolas, O .
CLINICAL BIOCHEMISTRY, 2000, 33 (07) :549-555
[4]   Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) [J].
Cleeman, JI ;
Grundy, SM ;
Becker, D ;
Clark, LT ;
Cooper, RS ;
Denke, MA ;
Howard, WJ ;
Hunninghake, DB ;
Illingworth, DR ;
Luepker, RV ;
McBride, P ;
McKenney, JM ;
Pasternak, RC ;
Stone, NJ ;
Van Horn, L ;
Brewer, HB ;
Ernst, ND ;
Gordon, D ;
Levy, D ;
Rifkind, B ;
Rossouw, JE ;
Savage, P ;
Haffner, SM ;
Orloff, DG ;
Proschan, MA ;
Schwartz, JS ;
Sempos, CT ;
Shero, ST ;
Murray, EZ .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (19) :2486-2497
[5]   A functional MRI study of three motor tasks in the evaluation of stroke recovery [J].
Cramer, SC ;
Nelles, G ;
Schaechter, JD ;
Kaplan, JD ;
Finklestein, SR ;
Rosen, BR .
NEUROREHABILITATION AND NEURAL REPAIR, 2001, 15 (01) :1-8
[6]   Atherogenic lipoprotein phenotype in end-stage renal failure: Origin and extent of small dense low-density lipoprotein formation [J].
Deighan, CJ ;
Caslake, MJ ;
McConnell, M ;
Boulton-Jones, JM ;
Packard, CJ .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2000, 35 (05) :852-862
[7]   Development of approximate formula for LDL-chol, LDL-apo B and LDL-chol/LDL-apo B as indices of hyperapobetalipoproteinemia and small dense LDL [J].
Hattori, Y ;
Suzuki, M ;
Tsushima, M ;
Yoshida, M ;
Tokunaga, Y ;
Wang, Y ;
Zhao, D ;
Takeuchi, M ;
Hara, Y ;
Ryomoto, KI ;
Ikebuchi, M ;
Kishioka, H ;
Mannami, T ;
Baba, S ;
Harano, Y .
ATHEROSCLEROSIS, 1998, 138 (02) :289-299
[8]  
Nauck M, 2002, CLIN CHEM, V48, P236
[9]  
Planella T, 1997, CLIN CHEM, V43, P808
[10]  
WARNICK GR, 1990, CLIN CHEM, V36, P15